BIIB vs SPY — which is stronger right now?
Same dated snapshot (2026-09-01): BIIB quality 100/100 vs SPY 100/100; engine LONG vs LONG. The comparison below is computed, dated, and auditable — not an opinion.
| Snapshot | 2026-09-01 · source: yahoo | |
|---|---|---|
| BIIB (Biogen) | SPY (SPDR S&P 500) | |
| Market / sector | us · Healthcare | us · ETF |
| Price | $221.50 | $766.08 |
| Quality score | 100/100 | 100/100 |
| Engine signal | LONG · 259 bars · uPnL +59.8% | LONG · 306 bars · uPnL +27.9% |
| Total return | +51.9% | +27.9% |
Thesis-break template (Healthcare)
flagship drug losing exclusivity; pivotal trial failure; pricing-policy shifts; payer consolidation
Cite this page
Balance Labs Research Desk (2026-09-01). "BIIB vs SPY — which is stronger right now?." balancelabs.app · https://balancelabs.app/stocks/compare/biib-vs-spy · CC BY 4.0
Ask anything
30 free credits monthly · no card required · research support, not advice
← compare hub · snapshot 2026-09-01 · not investment advice